No results were found for your search. Please adjust your search term or broaden your search criteria.
Still can't find what you are looking for? We can prepare Custom Research for you.
The Zurampic market is a subset of the Immune Disorders Drugs market, which focuses on treatments for conditions such as rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis. Zurampic is a medication used to reduce uric acid levels in the blood, which can help reduce the symptoms of these conditions. It is a xanthine oxidase inhibitor, meaning it works by blocking the enzyme responsible for producing uric acid.
The Zurampic market is a growing sector of the Immune Disorders Drugs market, with a number of companies offering treatments. These include AstraZeneca, Horizon Pharma, and Takeda Pharmaceuticals. Other companies, such as Novartis and Pfizer, are also researching and developing treatments for immune disorders. Show Less Read more
